期刊文献+

我院2015年门诊抗幽门螺杆菌处方分析 被引量:3

Analysis of prescriptions for anti-H. pylori in outpatient department in 2015
原文传递
导出
摘要 目的对我院抗幽门螺杆菌的门诊处方进行调查分析,为临床合理用药提供参考。方法利用医院信息系统调取我院2015年门诊抗幽门螺杆菌处方共1 019张,分析抗幽门螺杆菌药物的使用情况。结果铋剂四联疗法临床使用最多,其中铋剂+标准三联方案占36.11%,单张处方金额平均为262.76元,多为7 d疗程。抗菌药物中使用率最高的为克拉霉素缓释片,质子泵抑制剂中使用率最高的为雷贝拉唑胶囊,抗酸及胃黏膜保护药中使用率最高的为胶体果胶铋胶囊。结论抗幽门螺杆菌临床治疗方案众多且在不断改进,我院门诊处方在疗程、药品选择等方面有待进一步完善。 AIM To investigate and analyze the prescriptions for anti-H, pylori in outpatient department and provide reference for rational use of drug. METHODS Using a pharmacy administration software, the pre- scriptions for anti-H, pylori in outpatient department in 2015 was reviewed, the pattern of clinical use of anti-H. pylori was investigated. RESULTS Bismuth quadruple therapy was used most, standard triple therapy combined with bismuth was 36.11% , 262.76 yuan for the average amount of prescription and for 7 d course of treatment nor- mally;the highest rate of antibacterial drugs was clarithromycin sustained tablets, the highest rate of proton pump inhibitor was rabeprazole capsules, and the highest rate of antacid and gastric mucosal protectant was colloidal bis- muth pectin capsules. CONCLUSION The clinical projects of treatment for anti-H, pylori are numerous and ev- er-improving,and the prescriptions in outpatient department can he improved in the course of treatment, and the choices of drugs, etc.
出处 《中国临床药学杂志》 CAS 2017年第1期39-42,共4页 Chinese Journal of Clinical Pharmacy
关键词 幽门螺杆菌 门诊处方 处方分析 Helicobacter pylori outpatient prescription analysis of the prescription
  • 相关文献

参考文献11

二级参考文献129

共引文献1401

同被引文献38

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部